1. Home
  2. OCC vs COEP Comparison

OCC vs COEP Comparison

Compare OCC & COEP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OCC
  • COEP
  • Stock Information
  • Founded
  • OCC 1983
  • COEP 2017
  • Country
  • OCC United States
  • COEP United States
  • Employees
  • OCC N/A
  • COEP N/A
  • Industry
  • OCC Telecommunications Equipment
  • COEP Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • OCC Industrials
  • COEP Health Care
  • Exchange
  • OCC Nasdaq
  • COEP Nasdaq
  • Market Cap
  • OCC 76.4M
  • COEP 86.0M
  • IPO Year
  • OCC 1996
  • COEP N/A
  • Fundamental
  • Price
  • OCC $9.17
  • COEP $16.76
  • Analyst Decision
  • OCC
  • COEP
  • Analyst Count
  • OCC 0
  • COEP 0
  • Target Price
  • OCC N/A
  • COEP N/A
  • AVG Volume (30 Days)
  • OCC 116.7K
  • COEP 65.4K
  • Earning Date
  • OCC 09-11-2025
  • COEP 11-12-2025
  • Dividend Yield
  • OCC N/A
  • COEP N/A
  • EPS Growth
  • OCC N/A
  • COEP N/A
  • EPS
  • OCC N/A
  • COEP N/A
  • Revenue
  • OCC $72,694,849.00
  • COEP $263,555.00
  • Revenue This Year
  • OCC N/A
  • COEP N/A
  • Revenue Next Year
  • OCC N/A
  • COEP N/A
  • P/E Ratio
  • OCC N/A
  • COEP N/A
  • Revenue Growth
  • OCC 12.67
  • COEP N/A
  • 52 Week Low
  • OCC $2.02
  • COEP $2.31
  • 52 Week High
  • OCC $10.22
  • COEP $19.19
  • Technical
  • Relative Strength Index (RSI)
  • OCC 59.33
  • COEP 60.80
  • Support Level
  • OCC $8.50
  • COEP $16.00
  • Resistance Level
  • OCC $10.22
  • COEP $18.15
  • Average True Range (ATR)
  • OCC 0.84
  • COEP 1.60
  • MACD
  • OCC -0.04
  • COEP 0.07
  • Stochastic Oscillator
  • OCC 53.42
  • COEP 66.80

About OCC Optical Cable Corporation

Optical Cable Corp manufactures tight-buffered fiber optic & copper data communication cables, data communication connectivity solutions for enterprise markets, and customized solutions for specialty use & harsh environments. Its products and services include designs and customized products for specialty applications and harsh environments, cabling, connectors, patch cords, assemblies, racks, cabinets, datacom enclosures, patch panels, faceplates, and multi-media boxes. The company supplies its products and services to industries such as the military, industrial, mining, petrochemical, renewable energy and broadcast applications, and for the wireless carrier market.

About COEP Coeptis Therapeutics Holdings Inc.

Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio consists of multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

Share on Social Networks: